UK Markets closed

ANGLE plc (AGL.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
56.00+1.60 (+2.94%)
At close: 5:07PM BST

ANGLE plc

Surrey Research Park
10 Nugent Road
Guildford GU2 7AF
United Kingdom
44 14 8334 3434
http://www.angleplc.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Andrew David William NewlandFounder, CEO & Exec. Director244kN/A1962
Mr. Ian Francis GriffithsCFO, Fin. Director, Company Sec. & Exec. Director153kN/A1965
Dr. Madeline RepolletHead of Clinical LaboratoriesN/AN/AN/A
Mr. Paul SmithVP & Chief Exec. Officer of ANGLE Biosciences IncN/AN/AN/A
Mr. Martin CookeDirector of Manufacturing & Regulatory AffairsN/AN/A1969
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Corporate governance

ANGLE plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more